Skip to main content
DrugPrice

Eli Lilly — Drug Prices & Medicare Spending

Eli Lilly manufactures 21 drugs tracked by Medicare Part D with total spending of $17.8B.

21
Drugs Tracked
$17.8B
Medicare Spending
$234.65
Avg Cost/Claim
86%
Have Generics

Eli Lilly Drugs — Ranked by Medicare Spending

#DrugGeneric NameCost/ClaimGeneric?
1TrulicityDulaglutide$473.00No
2MounjaroTirzepatide$673.00No
3VerzenioAbemaciclib$5,628.00Yes
4HumalogInsulin Lispro$142.00Yes
5ZepboundTirzepatide (weight)$867.00Yes
6TaltzIxekizumab$3,546.00Yes
7BasaglarInsulin Glargine (biosimilar)$130.00No
8EmgalityGalcanezumab$688.00Yes
9ForteoTeriparatide$1,337.00Yes
10OlumiantBaricitinib$3,677.00Yes
11RetevmoSelpercatinib$14,375.00Yes
12LyumjevInsulin Lispro-aabc$278.00Yes
13HumatropeSomatropin$2,331.00Yes
14CymbaltaDuloxetine$19.00Yes
15StratteraAtomoxetine$189.00Yes
16DuloxetineDuloxetine Hydrochloride$21.00Yes
17JaypircaPirtobrutinib$13,000.00Yes
18ReyvowLasmiditan$206.00Yes
19OlanzapineOlanzapine$30.00Yes
20EffientPrasugrel$142.00Yes
21FluoxetineFluoxetine Hydrochloride$10.00Yes

Frequently Asked Questions

Eli Lilly manufactures 21 drugs tracked by Medicare Part D, with total annual spending of $17.8B.

Retevmo (Selpercatinib) is the most expensive at $14,375.00 per claim.

18 of 21 Eli Lilly drugs (86%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.